1. Home
  2. COEP vs OPXS Comparison

COEP vs OPXS Comparison

Compare COEP & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • OPXS
  • Stock Information
  • Founded
  • COEP 2017
  • OPXS 1987
  • Country
  • COEP United States
  • OPXS United States
  • Employees
  • COEP N/A
  • OPXS N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • OPXS Electronic Components
  • Sector
  • COEP Health Care
  • OPXS Technology
  • Exchange
  • COEP Nasdaq
  • OPXS Nasdaq
  • Market Cap
  • COEP 39.0M
  • OPXS 43.4M
  • IPO Year
  • COEP N/A
  • OPXS N/A
  • Fundamental
  • Price
  • COEP $9.31
  • OPXS $8.22
  • Analyst Decision
  • COEP
  • OPXS
  • Analyst Count
  • COEP 0
  • OPXS 0
  • Target Price
  • COEP N/A
  • OPXS N/A
  • AVG Volume (30 Days)
  • COEP 107.6K
  • OPXS 22.2K
  • Earning Date
  • COEP 05-27-2025
  • OPXS 05-13-2025
  • Dividend Yield
  • COEP N/A
  • OPXS N/A
  • EPS Growth
  • COEP N/A
  • OPXS 36.84
  • EPS
  • COEP N/A
  • OPXS 0.71
  • Revenue
  • COEP N/A
  • OPXS $37,431,000.00
  • Revenue This Year
  • COEP N/A
  • OPXS N/A
  • Revenue Next Year
  • COEP N/A
  • OPXS N/A
  • P/E Ratio
  • COEP N/A
  • OPXS $11.06
  • Revenue Growth
  • COEP N/A
  • OPXS 21.76
  • 52 Week Low
  • COEP $2.31
  • OPXS $5.36
  • 52 Week High
  • COEP $13.70
  • OPXS $10.30
  • Technical
  • Relative Strength Index (RSI)
  • COEP 49.50
  • OPXS 82.34
  • Support Level
  • COEP $7.81
  • OPXS $6.56
  • Resistance Level
  • COEP $10.86
  • OPXS $6.94
  • Average True Range (ATR)
  • COEP 1.45
  • OPXS 0.31
  • MACD
  • COEP 0.09
  • OPXS 0.16
  • Stochastic Oscillator
  • COEP 62.07
  • OPXS 90.99

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.

Share on Social Networks: